• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年多囊卵巢综合征:病理生理学及治疗意义

Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications.

作者信息

Pelusi Carla, Pasquali Renato

机构信息

Endocrinology Unit, Department of Internal Medicine, S.Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy.

出版信息

Treat Endocrinol. 2003;2(4):215-30. doi: 10.2165/00024677-200302040-00001.

DOI:10.2165/00024677-200302040-00001
PMID:15966558
Abstract

Polycystic ovary syndrome is a heterogeneous clinical syndrome, which has been defined as the association of hyperandrogenism with chronic anovulation in women without specific adrenal and pituitary gland disease. A family history of polycystic ovary syndrome may be present in a subset of patients; however, the genetic basis of the syndrome remains unclear. Most often, the age of onset is perimenarchal and it is characterized by the appearance of menstrual disturbances, hirsutism, acne, and more rarely, a male pattern of alopecia. In some cases, premature adrenarche may present as a precursor to the development of the syndrome. Polycystic ovary syndrome is also associated with metabolic disturbances, such as obesity and insulin resistance with hyperinsulinemia, for which the pathophysiological role in the development of the syndrome has been recognized. The therapeutic approaches to polycystic ovary syndrome include lifestyle modifications, dietary-induced weight loss, insulin-sensitizing agents, antiandrogens, and oral contraceptives. These treatments may improve the clinical manifestations of excess androgen production and normalize menses in many adolescents and young women with polycystic ovary syndrome. Early recognition of the syndrome and thus, early treatment, may prevent and possibly ameliorate all the symptoms and the potential later development of metabolic and cardiovascular complications.

摘要

多囊卵巢综合征是一种异质性临床综合征,被定义为在无特定肾上腺和垂体疾病的女性中,高雄激素血症与慢性无排卵的关联。一部分患者可能有多囊卵巢综合征家族史;然而,该综合征的遗传基础仍不清楚。最常见的发病年龄在月经初潮前后,其特征为月经紊乱、多毛、痤疮,较少见的还有男性型脱发。在某些情况下,肾上腺功能早现可能是该综合征发展的先兆。多囊卵巢综合征还与代谢紊乱相关,如肥胖以及伴有高胰岛素血症的胰岛素抵抗,其在该综合征发展中的病理生理作用已得到认可。多囊卵巢综合征的治疗方法包括生活方式改变、饮食诱导减重、胰岛素增敏剂、抗雄激素药物及口服避孕药。这些治疗可改善许多患有多囊卵巢综合征的青少年和年轻女性雄激素过多产生的临床表现,并使月经恢复正常。早期识别该综合征并尽早治疗,可能预防并或许改善所有症状以及后期潜在的代谢和心血管并发症的发生。

相似文献

1
Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications.青少年多囊卵巢综合征:病理生理学及治疗意义
Treat Endocrinol. 2003;2(4):215-30. doi: 10.2165/00024677-200302040-00001.
2
Treatment options of polycystic ovary syndrome in adolescence.青少年多囊卵巢综合征的治疗选择
Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:208-13.
3
Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.噻唑烷二酮类药物用于多囊卵巢综合征的治疗管理:对代谢和生殖异常的影响
Treat Endocrinol. 2006;5(3):171-87. doi: 10.2165/00024677-200605030-00005.
4
Polycystic ovary syndrome update in adolescence.青少年多囊卵巢综合征的最新进展
Curr Opin Pediatr. 2007 Aug;19(4):389-97. doi: 10.1097/MOP.0b013e328236743f.
5
Insulin-sensitizing agents in polycystic ovary syndrome.多囊卵巢综合征中的胰岛素增敏剂。
Eur J Endocrinol. 2006 Jun;154(6):763-75. doi: 10.1530/eje.1.02156.
6
Polycystic ovary syndrome.多囊卵巢综合征
Adolesc Med. 1999 Jun;10(2):321-36.
7
[Advance in treatment of polycystic ovary syndrome].[多囊卵巢综合征的治疗进展]
Pol Merkur Lekarski. 2005 Dec;19(114):848-54.
8
Metabolic Syndrome: Polycystic Ovary Syndrome.代谢综合征:多囊卵巢综合征。
FP Essent. 2015 Aug;435:30-42.
9
New adolescent polycystic ovary syndrome perspectives.青少年多囊卵巢综合征的新观点。
Minerva Pediatr. 2011 Feb;63(1):35-47.
10
Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome.胰岛素增敏剂在多囊卵巢综合征患者治疗中的潜在效用。
Treat Endocrinol. 2002;1(1):45-53. doi: 10.2165/00024677-200201010-00005.

引用本文的文献

1
Environment, Lifestyle, and Female Infertility.环境、生活方式与女性不孕
Reprod Sci. 2021 Mar;28(3):617-638. doi: 10.1007/s43032-020-00279-3. Epub 2020 Aug 3.
2
Vitamin D and Obesity: Two Interacting Players in the Field of Infertility.维生素 D 与肥胖:不孕领域的两个相互作用的因素。
Nutrients. 2019 Jun 27;11(7):1455. doi: 10.3390/nu11071455.
3
Contemporary approaches to the management of polycystic ovary syndrome.多囊卵巢综合征的当代管理方法。
Ther Adv Endocrinol Metab. 2018 Apr;9(4):123-134. doi: 10.1177/2042018818756790. Epub 2018 Feb 7.
4
New perspectives on the definition and management of polycystic ovary syndrome.多囊卵巢综合征定义和管理的新视角。
J Endocrinol Invest. 2018 Oct;41(10):1123-1135. doi: 10.1007/s40618-018-0832-1. Epub 2018 Jan 23.
5
Adverse effects of female obesity and interaction with race on reproductive potential.女性肥胖的不良影响以及种族因素对生殖潜能的相互作用。
Fertil Steril. 2017 Apr;107(4):868-877. doi: 10.1016/j.fertnstert.2017.02.114.
6
The effects of old, new and emerging medicines on metabolic aberrations in PCOS.新旧药物及新兴药物对多囊卵巢综合征代谢异常的影响。
Ther Adv Endocrinol Metab. 2012 Feb;3(1):27-47. doi: 10.1177/2042018812437355.